الفهرس | Only 14 pages are availabe for public view |
Abstract The purpose of this study is to study the hematological and biochemical parameters reflecting the acute phase protein associated with bronchopneumonia and comparative evaluation between meloxicam and phenyl-butazone as conjunctive for treatment of bronchopneumonia in sheep. For this purpose, 65 Ossimi sheep were used. Of all, ten sheep were selected and considered as a control group; however, 35 sheep were suffering from signs of acute bronchopneumonia and 20 were suffering from signs of chronic bronchopneumonia. Serum and plasma samples were collected from healthy and diseased sheep in order to determine haematological and biochemical examinations. The treated groups were classified to 3 groups each group was 11 sheep suffering from acute bronchopneumonia and the group (1) was treated with combination of Clamoxyl LA (Amoxicillin L.A.) S/C injection at a dose rate of 15 mg/kg B.W. every 48 hr for three days with Mobic ( Meloxicam ) which was administered I/M at dose rate of .5 mg/kg body weight for five days, while, the group (2) was treated with combination of Phenyloject (Phenyl-butazone) which was administered I/V at a dose rate of 4mg /kg B.W for five days and Clamoxyl LA (Amoxicillin LA), while, group (3) was treated with Clamoxyl LA (Amoxicillin LA) alone without NSAI drugs. The work revealed 1. APP especially haptoglobin proved to be accurate markers for bronchopneumonia in sheep while ά1 acid glycoprotein had no particular diagnostic value to assess the condition of bronchopneumonia in sheep. 2. The biochemical parameters, vitC, zinc, iron, significantly decreased during bronchopneumonia. Wheras, cupper, increases. These biochemical parameters were found to be sensitive indicators for inflammations and can be used for diagnosis of bronchopneumonia in sheep in field. 3. Meloxicam is superior to phenyl-butazone as adjuncts to antibacterial therapy in the treatment of bronchopneumonia in sheep in the field. |